These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24556911)

  • 1. A randomized trial of intravenous glutamine supplementation in trauma ICU patients.
    Pérez-Bárcena J; Marsé P; Zabalegui-Pérez A; Corral E; Herrán-Monge R; Gero-Escapa M; Cervera M; Llompart-Pou JA; Ayestarán I; Raurich JM; Oliver A; Buño A; García de Lorenzo A; Frontera G
    Intensive Care Med; 2014 Apr; 40(4):539-47. PubMed ID: 24556911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of the dipeptide N(2)-L-Alanyl-L-glutamine in traumatic patients admitted to the ICU: a prospective, randomized, double-blind, multicentre study].
    Pérez-Bárcena J; Marsé P; Cervera M; Frontera G; Llompart-Pou JA; Raurich JM; García de Lorenzo A
    Nutr Hosp; 2012; 27(1):116-22. PubMed ID: 22566310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients.
    Wernerman J; Kirketeig T; Andersson B; Berthelson H; Ersson A; Friberg H; Guttormsen AB; Hendrikx S; Pettilä V; Rossi P; Sjöberg F; Winsö O;
    Acta Anaesthesiol Scand; 2011 Aug; 55(7):812-8. PubMed ID: 21658010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation.
    Duska F; Fric M; Waldauf P; Pazout J; Andel M; Mokrejs P; Tůma P; Pachl J
    Crit Care Med; 2008 Jun; 36(6):1707-13. PubMed ID: 18496372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial.
    Zhou YP; Jiang ZM; Sun YH; Wang XR; Ma EL; Wilmore D
    JPEN J Parenter Enteral Nutr; 2003; 27(4):241-5. PubMed ID: 12903886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit.
    Pérez-Bárcena J; Crespí C; Regueiro V; Marsé P; Raurich JM; Ibáñez J; García de Lorenzo-Mateos A; Bengoechea JA
    Crit Care; 2010; 14(6):R233. PubMed ID: 21184675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children.
    Jordan I; Balaguer M; Esteban ME; Cambra FJ; Felipe A; Hernández L; Alsina L; Molero M; Villaronga M; Esteban E
    Clin Nutr; 2016 Feb; 35(1):34-40. PubMed ID: 25701159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study.
    Déchelotte P; Hasselmann M; Cynober L; Allaouchiche B; Coëffier M; Hecketsweiler B; Merle V; Mazerolles M; Samba D; Guillou YM; Petit J; Mansoor O; Colas G; Cohendy R; Barnoud D; Czernichow P; Bleichner G
    Crit Care Med; 2006 Mar; 34(3):598-604. PubMed ID: 16505644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
    Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
    JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients.
    Grau T; Bonet A; Miñambres E; Piñeiro L; Irles JA; Robles A; Acosta J; Herrero I; Palacios V; Lopez J; Blesa A; Martínez P;
    Crit Care Med; 2011 Jun; 39(6):1263-8. PubMed ID: 21336131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The local vascular tolerance to an intravenous infusion of a concentrated glutamine solution in ICU patients.
    Berg A; Forsberg E; Wernerman J
    Clin Nutr; 2002 Apr; 21(2):135-9. PubMed ID: 12056785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intravenous alanyl-glutamine supplementation on plasma glutathione levels in intensive care unit trauma patients receiving enteral nutrition: the results of a randomized controlled trial.
    Eroglu A
    Anesth Analg; 2009 Aug; 109(2):502-5. PubMed ID: 19608826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.
    Mori M; Rooyackers O; Smedberg M; Tjäder I; Norberg A; Wernerman J
    Crit Care; 2014 Apr; 18(2):R72. PubMed ID: 24731231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma glutamine after multiple trauma: relationship with intracellular glutamine in polymorphonuclear neutrophils during prolonged ICU stay.
    Engel JM; Mühling J; Weiss S; Löhr T; Simonis Y; Menges T; Hempelmann G
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):707-13. PubMed ID: 12803588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study.
    Pytlík R; Benes P; Patorková M; Chocenská E; Gregora E; Procházka B; Kozák T
    Bone Marrow Transplant; 2002 Dec; 30(12):953-61. PubMed ID: 12476290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.
    Luo M; Bazargan N; Griffith DP; Estívariz CF; Leader LM; Easley KA; Daignault NM; Hao L; Meddings JB; Galloway JR; Blumberg JB; Jones DP; Ziegler TR
    Clin Nutr; 2008 Apr; 27(2):297-306. PubMed ID: 18258342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
    Stehle P; Ellger B; Kojic D; Feuersenger A; Schneid C; Stover J; Scheiner D; Westphal M
    Clin Nutr ESPEN; 2017 Feb; 17():75-85. PubMed ID: 28361751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients.
    Tjäder I; Rooyackers O; Forsberg AM; Vesali RF; Garlick PJ; Wernerman J
    Intensive Care Med; 2004 Feb; 30(2):266-275. PubMed ID: 14722645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients.
    Pradelli L; Povero M; Muscaritoli M; Eandi M
    Eur J Clin Nutr; 2015 May; 69(5):546-51. PubMed ID: 25469466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients.
    Goeters C; Wenn A; Mertes N; Wempe C; Van Aken H; Stehle P; Bone HG
    Crit Care Med; 2002 Sep; 30(9):2032-7. PubMed ID: 12352037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.